• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
MRK

MRK

Merck & Co., Inc.

NYSEHealthcareDrug Manufacturers - GeneralUS

USD114.80

-0.85 (-0.73%)

Rating:B

Company Profile

CEO

Robert Davis

IPO Date

1978-01-13

Sector

Healthcare

Industry

Drug Manufacturers - General

Exchange

NYSE

Country

US

Market Metrics

Open

$115.44

Prev. Close

$115.65

Day Low

$114.73

Day High

$117.33

52W Low

$76.66

52W High

$125.14

Market Cap

$283.54B

Volume

6.05M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

58.0%

Avg Negative

13.2%

Avg Neutral

28.7%

News Feed

Here is What to Know Beyond Why Merck & Co., Inc. (MRK) is a Trending Stock

zacks.com·5/28/2026·↑ positive

Merck to Participate in the Jefferies Global Healthcare Conference

businesswire.com·5/28/2026·↑ positive

Merck and Mastercard are seeing real agentic AI results. Both say the plumbing came first.

venturebeat.com·5/27/2026·↑ positive

Merck chicken bronchitis vaccine approved for use in China

reuters.com·5/27/2026·↑ positive

Merck Announces Third-Quarter 2026 Dividend

businesswire.com·5/26/2026·↓ negative

Merck stock jumps as Keytruda combo trials boost cancer pipeline

invezz.com·5/22/2026·↑ positive

Will Weak Gardasil Sales Continue to Ail MRK's Vaccines Sales in 2026?

zacks.com·5/22/2026·↓ negative

Pharma Stock Pops On European Seal of Approval

schaeffersresearch.com·5/22/2026·↑ positive

Merck Stock Climbs on Cancer Data. Why the Drugmaker Is More Than a One-Trick Pony.

barrons.com·5/22/2026·↑ positive

Merck Stock Zooms Closer To A Breakout On 'A New Chapter' In Cancer

investors.com·5/22/2026·↑ positive